We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+9.16%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$5.79B
AUM Growth
+$493M
Cap. Flow
+$186M
Cap. Flow %
3.21%
Top 10 Hldgs %
23.53%
Holding
286
New
43
Increased
91
Reduced
94
Closed
31

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$52.9M
2
CNQ icon
Canadian Natural Resources
CNQ
+$43.8M
3
ABT icon
Abbott
ABT
+$37.3M
4
AMGN icon
Amgen
AMGN
+$35M
5
AME icon
Ametek
AME
+$28.7M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$66.2M
2
N
Netsuite Inc
N
+$40M
3
AGN
Allergan plc
AGN
+$39.6M
4
BMY icon
Bristol-Myers Squibb
BMY
+$38.9M
5
BCR
CR Bard Inc.
BCR
+$33.3M

Sector Composition

Rank Sector Weight
1 Technology 21.6%
2 Healthcare 21.19%
3 Financials 20.46%
4 Communication Services 9.97%
5 Consumer Discretionary 5.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
251
CALL
Microsoft
MSFT
$2.89T
– –
-620,000
Closed -$31.7M
NXPI icon
252
NXP Semiconductors
NXPI
$67.6B
– –
-19,780
Closed -$1.55M
ORCL icon
253
Oracle
ORCL
$345B
– –
-709,912
Closed -$29.1M
SCOR icon
254
Comscore
SCOR
$107M
– –
-2,169
Closed -$1.04M
SPSC icon
255
SPS Commerce
SPSC
$2.41B
– –
-108,664
Closed -$3.29M
TU icon
256
Telus
TU
$16.2B
– –
-99,000
Closed -$1.84M
UHS icon
257
Universal Health Services
UHS
$9.64B
– –
-140,000
Closed -$18.8M
PRTK
258
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
– –
-59,230
Closed -$824K
TWTR
259
DELISTED
Twitter, Inc.
TWTR
– –
-1,081,124
Closed -$20.3M
LOGM
260
DELISTED
LogMein, Inc.
LOGM
– –
-171,719
Closed -$10.9M
AGN
261
DELISTED
Allergan plc
AGN
– –
-171,500
Closed -$39.6M
IDTI
262
DELISTED
Integrated Device Technology I
IDTI
– –
-260,023
Closed -$5.23M
CIVI
263
DELISTED
Civitas Solutions, Inc.
CIVI
– –
-875,000
Closed -$18.2M
FTRPR
264
DELISTED
Frontier Communications Corporation 11.125% Series A Mandatory Convertible Preferred Stock
FTRPR
– –
-242,400
Closed -$23M
TMUSP
265
DELISTED
T-Mobile US, Inc.5.50% Mandatory Convertible Preferred Stock, Series A
TMUSP
– –
-56,500
Closed -$4.14M
WBMD
266
DELISTED
WebMD Health Corp.
WBMD
– –
-40,400
Closed -$2.35M
APIC
267
DELISTED
Apigee Corporation Common Stock
APIC
– –
-47,278
Closed -$577K
VTAE
268
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
– –
-300,000
Closed -$3.24M
SHPG
269
DELISTED
Shire pic
SHPG
– –
-7,722
Closed -$1.42M
7 8 9 10
11

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q3 2016 Portfolio in Review

As of Q3 2016, Polar Capital held 286 positions worth $5.79B, up 9.3% from $5.3B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Polar Capital deployed $186M of net new capital in Q3 2016, opening 43 new positions and adding to 91 existing holdings. Its largest new stake was Canadian Natural Resources: 2,876,960 shares worth $52.7M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Pfizer, an estimated $66.2M trimmed.

  • Polar Capital's largest Q3 2016 buy was Canadian Natural Resources: 2,876,960 shares worth $52.7M.
  • Polar Capital added most to Merck in Q3 2016, an estimated $52.9M increase.
  • Polar Capital's biggest Q3 2016 reduction was Pfizer, cutting an estimated $66.2M.
  • Polar Capital fully exited Allergan plc in Q3 2016, selling an estimated $39.6M.
  • Polar Capital's ten largest holdings make up 24% of its $5.79B portfolio in Q3 2016.
  • Polar Capital opened 43 new positions and closed 31 in Q3 2016.
  • Polar Capital's portfolio value rose 9.3% quarter-over-quarter to $5.79B.

Based on Polar Capital's 13F filing for Q3 2016, filed 14 Nov 2016.